SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950144-08-002492
Filing Date
2008-04-01
Accepted
2008-03-31 17:40:08
Documents
5
Period of Report
2008-03-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 KING PHARMACEUTICALS, INC. - FORM 8-K g12565e8vk.htm 8-K 15028
2 EX-10.01 FORM OF OPTION CERTIFICATE AND NONSTATUTORY STOCK OPTION AGREEMENT g12565exv10w01.htm EX-10.01 34832
3 EX-10.02 FORM OF RESTRICTED STOCK CERTIFICATE AND RESTRICTED STOCK GRANT AGREEME g12565exv10w02.htm EX-10.02 27457
4 EX-10.03 FORM OF LONG-TERM PERFORMANCE UNIT AWARD AGREEMENT g12565exv10w03.htm EX-10.03 30548
5 EX-10.04 FORM OF LONG-TERM PERFORMANCE UNIT AWARD AGREEMENT g12565exv10w04.htm EX-10.04 31113
  Complete submission text file 0000950144-08-002492.txt   140518
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filer) CIK: 0001047699 (see all company filings)

IRS No.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15875 | Film No.: 08726526
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1